Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

HRMY holding history

Harmony Biosciences Holdings, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HRMY overviewAll 13F holders of HRMYFull Q2 2026 holdings

Shares (Q2 2026)
255,810
Value
$9.31M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of HRMY by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026255,810$9.31M<0.1%−329,813−56.3%ReducedHolders
Q1 2026585,623$16.4M<0.1%+165,213+39.3%AddedHolders
Q4 2025420,410$15.7M<0.1%+352,398+518.1%AddedHolders
Q3 202568,012$1.87M<0.1%+68,012NewHolders
Q2 20250$00.0%−862,406−100.0%Sold outHolders
Q1 2025862,406$28.6M<0.1%−505,826−37.0%ReducedHolders
Q4 20241,368,232$47.1M<0.1%+1,213,556+784.6%AddedHolders
Q3 2024154,676$6.19M<0.1%−529,642−77.4%ReducedHolders
Q2 2024684,318$20.6M<0.1%+102,698+17.7%AddedHolders
Q1 2024581,620$19.5M<0.1%+502,887+638.7%AddedHolders
Q4 202378,733$2.54M<0.1%−163,347−67.5%ReducedHolders
Q3 2023242,080$7.93M<0.1%−558,780−69.8%ReducedHolders
Q2 2023800,860$28.2M<0.1%+269,053+50.6%AddedHolders
Q1 2023531,807$17.4M<0.1%+395,854+291.2%AddedHolders
Q4 2022135,953$7.49M<0.1%−8,250−5.7%ReducedHolders
Q3 2022144,203$6.39M<0.1%+70,740+96.3%AddedHolders
Q2 202273,463$3.58M<0.1%−95,016−56.4%ReducedHolders
Q1 2022168,479$8.20M<0.1%+78,048+86.3%AddedHolders
Q4 202190,431$3.86M<0.1%+49,384+120.3%AddedHolders
Q3 202141,047$1.57M<0.1%−3,724−8.3%ReducedHolders
Q2 202144,771$1.26M<0.1%−6,008−11.8%ReducedHolders
Q1 202150,779$1.68M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.